Не сдохни! Еда в борьбе за жизнь

22
18
20
22
24
26
28
30

‹‹113››. Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2014;29(9):541–9.

‹‹114››. Meng X, Munishkina LA, Fink AL, Uversky VN. Effects of various flavonoids on the α-synuclein fibrillation process. Parkinson’s Dis. 2010;2010:650794.

‹‹115››. Strathearn KE, Yousef GG, Grace MH, Roy SA, et al. Neuroprotective effects of anthocyaninand proanthocyanidin-rich extracts in cellular models of Parkinson’s disease. Brain Res. 2014; 1555:60–77.

‹‹116››. Golbe LI, Farrell TM, Davis PH. Case-control study of early life dietary factors in Parkinson’s disease. Arch Neurol. 1988;45(12):1350–3.

‹‹117››. Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurol. 2012;78(15):1138–45.

‹‹118››. Kukull WA. An apple a day to prevent Parkinson disease: reduction of risk by flavonoids. Neurol. 2012;78(15):1112–3.

‹‹119››. Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012;78(15):1138–45.

‹‹120››. Serafini M, Testa MF, Villain D, et al. Antioxidant activity of blueberry fruit is impaired by association with milk. Free Radic Biol Med. 2009;46(6):769–74.

‹‹121››. Jekanowski M. Survey says: a snapshot of rendering. Render Magazine. 2011;April:58–61.

‹‹122››. Schepens PJ, Covaci A, Jorens PG, Hens L, Scharpé S, van Larebeke N. Surprising findings following a Belgian food contamination with polychlorobiphenyls and dioxins. Environ Health Perspect. 2001;109(2):101–3.

‹‹123››. Dórea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.

‹‹124››. Dórea JG. Fish meal in animal feed and human exposure to persistent bioaccumulative and toxic substances. J Food Prot. 2006;69(11):2777–85.

‹‹125››. Moser GA, McLachlan MS. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere. 2001;45(2):201–11.

‹‹126››. Dórea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.

‹‹127››. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.

‹‹128››. Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF. Parkinson’s disease and tea: a quantitative review. J Am Coll Nutr. 2009;28(1):1–6.

‹‹129››. Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson’s disease in a large cohort of men and women. Mov Disord. 2012;27(10):1276–82.

‹‹130››. Nakaso K, Ito S, Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells. Neurosci Lett. 2008;432(2):146–50.

‹‹131››. Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.

‹‹132››. Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.